Literature DB >> 15556624

Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.

Eliska Svastová1, Alzbeta Hulíková, Monika Rafajová, Miriam Zat'ovicová, Adriana Gibadulinová, Angela Casini, Alessandro Cecchi, Andrea Scozzafava, Claudiu T Supuran, Jaromír Pastorek, Silvia Pastoreková.   

Abstract

Acidic extracellular pH (pHe) is a typical attribute of a tumor microenvironment, which has an impact on cancer development and treatment outcome. It was believed to result from an accumulation of lactic acid excessively produced by glycolysis. However, metabolic profiles of glycolysis-impaired tumors have revealed that CO2 is a significant source of acidity, thereby indicating a contribution of carbonic anhydrase (CA). The tumor-associated CA IX isoform is the best candidate, because its extracellular enzyme domain is highly active, expression is induced by hypoxia and correlates with poor prognosis. This study provides the first evidence for the role of CA IX in the control of pHe. We show that CA IX can acidify the pH of the culture medium in hypoxia but not in normoxia. This acidification can be perturbed by deletion of the enzyme active site and inhibited by CA IX-selective sulfonamides, which bind only to hypoxic cells containing CA IX. Our findings suggest that hypoxia regulates both expression and activity of CA IX in order to enhance the extracellular acidification, which may have important implications for tumor progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556624     DOI: 10.1016/j.febslet.2004.10.043

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  184 in total

1.  Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells.

Authors:  Ying Li; Hai Wang; Chingkuang Tu; Kathleen T Shiverick; David N Silverman; Susan C Frost
Journal:  Biochim Biophys Acta       Date:  2010-10-12

Review 2.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

Review 3.  Role of monocarboxylate transporters in human cancers: state of the art.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; João Azevedo-Silva; Margarida Casal; Fernando C Schmitt; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

4.  Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers.

Authors:  Massimo Aureli; Nicoletta Loberto; Rosaria Bassi; Anita Ferraretto; Silvia Perego; Patrizia Lanteri; Vanna Chigorno; Sandro Sonnino; Alessandro Prinetti
Journal:  Neurochem Res       Date:  2012-02-23       Impact factor: 3.996

5.  Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.

Authors:  Feray Kockar; Hatice Yildrim; Rahsan Ilikci Sagkan; Carsten Hagemann; Yasemin Soysal; Jelena Anacker; Ahmed Ayad Hamza; Dirk Vordermark; Michael Flentje; Harun M Said
Journal:  World J Clin Oncol       Date:  2012-06-10

6.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

7.  Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.

Authors:  Narges K Tafreshi; Mark C Lloyd; Joshua B Proemsey; Marilyn M Bui; Jongphil Kim; Robert J Gillies; David L Morse
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

8.  Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.

Authors:  Harun M Said; Adrian Staab; Carsten Hagemann; Giles H Vince; Astrid Katzer; Michael Flentje; Dirk Vordermark
Journal:  J Neurooncol       Date:  2006-08-31       Impact factor: 4.130

9.  Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.

Authors:  Caroli Genis; Katherine H Sippel; Nicolette Case; Wengang Cao; Balendu Sankara Avvaru; Lawrence J Tartaglia; Lakshmanan Govindasamy; Chingkuang Tu; Mavis Agbandje-McKenna; David N Silverman; Charles J Rosser; Robert McKenna
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

10.  Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma.

Authors:  Martina Takacova; Maria Bartosova; Lucia Skvarkova; Miriam Zatovicova; Ivana Vidlickova; Lucia Csaderova; Monika Barathova; Jan Breza; Peter Bujdak; Jaromir Pastorek; Jan Breza; Silvia Pastorekova
Journal:  Oncol Lett       Date:  2012-10-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.